1f92: Difference between revisions

Line 1:

[[Image:1f92.~~gif~~|left|200px]]

[[Image:1f92.png|left|200px]]

<!--

Line 9:

Line 10:

~~'''~~UROKINASE PLASMINOGEN ACTIVATOR B CHAIN-UKI-1D COMPLEX~~'''~~

===UROKINASE PLASMINOGEN ACTIVATOR B CHAIN-UKI-1D COMPLEX===

~~==Overview==~~

<!--

~~Urokinase is a serine protease involved in cancer growth and metastasis. Here we present~~ the ~~first urokinase crystal structure in complex with reversible inhibitors~~ at 2.~~1 and 2~~.6 A resolution. These inhibitor complex structures have been obtained from crystals of engineered urokinase type plasminogen activator designed to obtain a crystal form open for inhibitor soaking. The mutant C122S loses its flexible A-chain upon activation cleavage and crystallizes in the presence of benzamidine, ~~which was later displaced by~~ the ~~desired inhibitor~~. ~~This new soakable crystal form turned out to be of great value in the process of structure~~-~~based drug design. The evaluated binding mode of amiloride, and UKI~~-~~1D revealed a new subsite of the primary specificity pocket of urokinase that will be employed in the future ligand optimisation process.~~

The line below this paragraph, {{ABSTRACT_PUBMED_10926521}}, adds the Publication Abstract to the page

(as it appears on PubMed at http://www.pubmed.gov), where 10926521 is the PubMed ID number.

-->

==About this Structure==

Line 34:

Line 38:

[[Category: Serine protease]]

[[Category: Urokinase]]

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on ~~Fri May~~ ~~2 16~~:03:00 2008''

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 02:53:34 2008''

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 1: / Line 1: @@
-[[Image:1f92.gif|left|200px]]
+{{Seed}}
+[[Image:1f92.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_1f92|  PDB=1f92  |  SCENE=  }}
-'''UROKINASE PLASMINOGEN ACTIVATOR B CHAIN-UKI-1D COMPLEX'''
+===UROKINASE PLASMINOGEN ACTIVATOR B CHAIN-UKI-1D COMPLEX===
-==Overview==
+<!--
-Urokinase is a serine protease involved in cancer growth and metastasis. Here we present the first urokinase crystal structure in complex with reversible inhibitors at 2.1 and 2.6 A resolution. These inhibitor complex structures have been obtained from crystals of engineered urokinase type plasminogen activator designed to obtain a crystal form open for inhibitor soaking. The mutant C122S loses its flexible A-chain upon activation cleavage and crystallizes in the presence of benzamidine, which was later displaced by the desired inhibitor. This new soakable crystal form turned out to be of great value in the process of structure-based drug design. The evaluated binding mode of amiloride, and UKI-1D revealed a new subsite of the primary specificity pocket of urokinase that will be employed in the future ligand optimisation process.
+The line below this paragraph, {{ABSTRACT_PUBMED_10926521}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 10926521 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_10926521}}
 ==About this Structure==
@@ Line 34: / Line 38: @@
 [[Category: Serine protease]]
 [[Category: Urokinase]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 16:03:00 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul  1 02:53:34 2008''